Clinical Outcomes and Retreatment Pathways Following Intradetrusor OnabotulinumtoxinA in Women with Refractory Idiopathic Overactive Bladder.

Gökçen İşcan R, Yılmaz MB, Bucak B, Tosun Ö, Güray Uzun M, Karakuş SS, Kumru P

Open source

DOI
10.3390/jcm15186977
Published
2026 Sep 9
Container
Journal of clinical medicine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/jcm15186977,
  title = {Clinical Outcomes and Retreatment Pathways Following Intradetrusor OnabotulinumtoxinA in Women with Refractory Idiopathic Overactive Bladder.},
  author = {Gökçen İşcan R and Yılmaz MB and Bucak B and Tosun Ö and Güray Uzun M and Karakuş SS and Kumru P},
  year = {2026},
  journal = {Journal of clinical medicine},
  doi = {10.3390/jcm15186977},
  url = {https://doi.org/10.3390/jcm15186977}
}

RIS

TY  - JOUR
TI  - Clinical Outcomes and Retreatment Pathways Following Intradetrusor OnabotulinumtoxinA in Women with Refractory Idiopathic Overactive Bladder.
AU  - Gökçen İşcan R
AU  - Yılmaz MB
AU  - Bucak B
AU  - Tosun Ö
AU  - Güray Uzun M
AU  - Karakuş SS
AU  - Kumru P
PY  - 2026
JO  - Journal of clinical medicine
DO  - 10.3390/jcm15186977
UR  - https://doi.org/10.3390/jcm15186977
ER  - 

APA

R, G. İ., MB, Y., B, B., Ö, T., M, G. U., SS, K., & P, K. (2026). Clinical Outcomes and Retreatment Pathways Following Intradetrusor OnabotulinumtoxinA in Women with Refractory Idiopathic Overactive Bladder.. Journal of clinical medicine. https://doi.org/10.3390/jcm15186977

Source records